Pharmacological inhibiting STAT5 for the treatment of FLT3‐ITD‐positive acute myeloid leukemia with triciribine phosphate monohydrate

por Wu, Hong, Ge, Juan, Zou, Fengming, Jiang, Zongru, Wang, Beilei, Yuan, Xinyu, Long, Kaili, Liu, Jing, Wang, Wenchao, Liu, Qingsong
Publicado 2023

T. gondii rhoptry protein ROP18 induces apoptosis of neural cells via endoplasmic reticulum stress pathway

por Wan, Lijuan, Gong, Lingli, Wang, Wei, An, Ran, Zheng, Meijuan, Jiang, Zongru, Tang, Yuewen, Zhang, Yihua, Chen, He, Yu, Li, Shen, Jilong, Du, Jian
Publicado 2015

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent

por Jiang, Zongru, Wang, Li, Liu, Xuesong, Chen, Cheng, Wang, Beilei, Wang, Wenliang, Hu, Chen, Yu, Kailin, Qi, Ziping, Liu, Qingwang, Wang, Aoli, Liu, Jing, Hong, Guangchen, Wang, Wenchao, Liu, Qingsong
Publicado 2020

Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies

por Mei, Husheng, Wu, Hong, Yang, Jing, Zhou, Bin, Wang, Aoli, Hu, Chen, Qi, Shuang, Jiang, Zongru, Zou, Fengming, Wang, Beilei, Liu, Feiyang, Chen, Yongfei, Wang, Wenchao, Liu, Jing, Liu, Qingsong
Publicado 2023

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours

por Liu, Juan, Gao, Jingjing, Wang, Aoli, Jiang, Zongru, Qi, Shuang, Qi, Ziping, Liu, Feiyang, Yu, Kailin, Cao, Jiangyan, Chen, Cheng, Hu, Chen, Wu, Hong, Wang, Li, Wang, Wenchao, Liu, Qingsong, Liu, Jing
Publicado 2022

Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs)

por Yu, Kailin, Liu, Xuesong, Jiang, Zongru, Hu, Chen, Zou, Fengming, Chen, Cheng, Ge, Juan, Wu, Jiaxin, Liu, Xiaochuan, Wang, Aoli, Wang, Wenliang, Wang, Wenchao, Qi, Ziping, Wang, Beilei, Wang, Li, Yan, Hezhong, Wang, Jiaoxue, Ren, Tao, Tang, Jun, Liu, Qingsong, Liu, Jing
Publicado 2017